BUDGET IMPACT ANALYSIS OF OBINUTUZUMAB AND IBRUTINIB IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA IN RUSSIA

Author(s)

Derkach EV1, Rebrova OY1, Fedyaeva VK2
1The Russian Presidential Academy of National Economy and Public Administration, Moscow, Russia, 2FSBI Center of Healthcare Quality Assessment and Control of the Ministry of Health of the Russian Federation, Moscow, Russia

Conference/Value in Health Info

2016-10, ISPOR Europe 2016, Vienna, Austria

Value in Health, Vol. 19, No. 7 (November 2016)

Code

PSY41

Topic

Economic Evaluation

Topic Subcategory

Budget Impact Analysis

Disease

Systemic Disorders/Conditions

Explore Related HEOR by Topic

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×